- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05516836
Addressing Post-COVID-19 Musculoskeletal Symptoms
Addressing Post-COVID-19 Musculoskeletal Symptoms Through Telemedicine
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Eleuterio A. Sánchez Romero, PhD
- Phone Number: +34 617123563
- Email: eleuterio.sanchez@universidadeuropea.es
Study Contact Backup
- Name: Lidia Martínez Rolando, MSc
- Phone Number: +34 689895710
- Email: lidiamrfisioterapia@gmail.com
Study Locations
-
-
-
Madrid, Spain, 28014
- Recruiting
- Eleuterio A. Sánchez Romero
-
Contact:
- Eleuterio A. Sánchez Romero
- Phone Number: 617123563
- Email: elusanchezromero@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Need to be post-COVID-19 patients (ICU or non-ICU)
- Musculoskeletal symptoms
- Be of adult age (over 18 years)
Exclusion Criteria:
- Myocardial infarction
- Uncontrolled arrhythmia
- Recent pulmonary thromboembolism
- Terminal illness
- Patients undergoing lower limb unloading
- Lower or upper limb fractures in the last three months
- Severe pain (score greater than 7 on the VAS of 10 points)
- Suffering from the previous pathology that causes neuromuscular weakness
- Be younger than 18 and older than 65 years old
- Influenced by medication that does not allow assessment of the real muscular functionality of the patient
- Patients with cognitive impairment that would prevent them from understanding and collaborating in the performance of the rehabilitation program plus telemedicine
- Patients with cardiorespiratory instability and uncontrolled arterial hypertension
- Systemic illness (tumor and rheumatologic diseases)
- Recent unrelated trauma
- Limiting psychiatric pathology
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Multicomponent exercise program + Telemedicine
The multicomponent exercise program lasted 6 weeks with sessions twice a week for a total of 12 sessions. It will have a duration of forty minutes in which the first five and the last five will be performed at a constant load of 5% of its maximum load corresponding to the "warm-up" and "return to calm". Individualized respiratory physiotherapy exercises (diaphragmatic stimulation, positive expiratory pressure exercises, alveolar retraining and strengthening of the inspiratory musculature) will also be performed. A once a week telemedicine session will be carried out with the case group only before the face-to-face sessions, consisting of education, respiratory exercise, mobility and stretching, giving them a place to provide feedback and re-evaluate patients mid-treatment and will be aimed at assessing improvement and improving therapeutic adherence |
Each exercise session will have a duration of forty minutes in which the thirty minutes of intervallic work will be distributed as follows: twenty seconds until reaching 60% of their maximum load in the first seven sessions, adding five watts each day until reaching 80% of their maximum load in the fourteen sessions and seventy seconds of rest at 20% of their maximum load. At the end of the sessions, strengthening exercises will be performed with elastic bands, adapting their resistance according to the characteristics of the patients, of the lower limbs and of the upper limbs. Individualized respiratory physiotherapy exercises (diaphragmatic stimulation, positive expiratory pressure exercises, alveolar retraining and strengthening of the inspiratory musculature) will also be performed.
A once a week telemedicine session will be carried out with the case group only before the face-to-face sessions, consisting of education, respiratory exercise, mobility and stretching, giving them a place to provide feedback and re-evaluate patients mid-treatment and will be aimed at assessing improvement and improving therapeutic adherence.
|
Active Comparator: Multicomponent exercise program
The multicomponent exercise program lasted 6 weeks with sessions twice a week for a total of 12 sessions.
It will have a duration of forty minutes in which the first five and the last five will be performed at a constant load of 5% of its maximum load corresponding to the "warm-up" and "return to calm".
Individualized respiratory physiotherapy exercises (diaphragmatic stimulation, positive expiratory pressure exercises, alveolar retraining and strengthening of the inspiratory musculature) will also be performed.
|
Each exercise session will have a duration of forty minutes in which the thirty minutes of intervallic work will be distributed as follows: twenty seconds until reaching 60% of their maximum load in the first seven sessions, adding five watts each day until reaching 80% of their maximum load in the fourteen sessions and seventy seconds of rest at 20% of their maximum load. At the end of the sessions, strengthening exercises will be performed with elastic bands, adapting their resistance according to the characteristics of the patients, of the lower limbs and of the upper limbs. Individualized respiratory physiotherapy exercises (diaphragmatic stimulation, positive expiratory pressure exercises, alveolar retraining and strengthening of the inspiratory musculature) will also be performed. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Manual grip strength
Time Frame: Change from base line and at the end of each of the six weeks
|
Grip strength will be measured in the affected hand and in the healthy hand (measuring the maximum grip strength).
For this measurement, Handgrip strength averaging the result of three attempts with the dominant hand using a Baseline© model pear dynamometer
|
Change from base line and at the end of each of the six weeks
|
Quality of life according to Short- Form 36 Questionnaire (SF - 36)
Time Frame: Change from base line and at the end of each of the six weeks
|
SF - 36 is an instrument to asses health - related quality of life, this evaluates eight spheres (physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health) scored from zero to 100, where 100 is equivalent to no disability and zero is equivalent to maximum disability.
|
Change from base line and at the end of each of the six weeks
|
Assessment of exercise capacity
Time Frame: Change from base line and at the end of each of the six weeks
|
Exercise capacity will be measured with a six-minute walking test (6MWT), a sub-maximal exercise test which consists of the patient walking for six minutes along a 30 - meter corridor with two cones marking the distance to be covered while being given a series of cues.
|
Change from base line and at the end of each of the six weeks
|
COPD Assessment Test (CAT)
Time Frame: Change from base line and at the end of each of the six weeks
|
CAT is an eight item questionnaire to assess: cough, sputum, chest tightness, breathlessness, activity limitation, confidence leaving home, sleep and energy scored from zero to 4 in each item, zero corresponds to the least affected and 5 to the most affected
|
Change from base line and at the end of each of the six weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dyspnea using the modified Medical Research Council dyspnea scale (mMRC)
Time Frame: Change from base line and at the end of each of the six weeks
|
This scale assess dyspnea in activities of daily living scored from 0 (absence of dyspnea during intense exercise) to 4 (dyspnea prevents the patient from leaving the house or appears with tasks such as dressing or undressing)
|
Change from base line and at the end of each of the six weeks
|
Assessment of perceived pain
Time Frame: Change from base line and at the end of each of the six weeks
|
The numerical pain intensity scale adds a numerical graduation where 1 is no pain and 10 is the worst pain imaginable.
The confidence and reliability of this scale has been approved and validated in different studies.
|
Change from base line and at the end of each of the six weeks
|
STAI (State-Trait Anxiety)
Time Frame: Change from base line and at the end of each of the six weeks
|
Questionnaire composed of 20 items with 4 points each that evaluate "state anxiety" (transitory emotional condition influenced by environmental factors that decrease or increase anxiety) and another 20 that evaluate "trait anxiety" (personality factor that predisposes to suffer or not suffer anxiety).
The 2-part score ranks patients at a percentile to the general population.
The higher the score, the greater the anxiety.
It is one of the most widely used tools in research to measure levels of general anxiety.
|
Change from base line and at the end of each of the six weeks
|
TSK (Tampa Scale for Kinesiophobia)
Time Frame: Change from base line and at the end of each of the six weeks
|
7 items, 4 points each where higher scores indicate higher levels of fear of movement.
|
Change from base line and at the end of each of the six weeks
|
Beck II (Depression)
Time Frame: Change from base line and at the end of each of the six weeks
|
A 21-item scale used to assess the severity of depression.
The patient has to select for each item the response alternative that best reflects his/her state during the last week.
The total score is obtained by adding up the values of the selected items, which range from 0 to 3. The commonly accepted cut-off points for grading intensity/severity are as follows: 0 to 9, no depression; 10 to 18, mild depression; 19 to 29, moderate depression, and ≥ 30 points, severe depression.
|
Change from base line and at the end of each of the six weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Jorge Hugo Villafañe, PhD, IRCCS Fondazione Don Carlo Gnocchi
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Addressing post-COVID-19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
Massachusetts General HospitalRecruitingPost Acute COVID-19 Syndrome | Long COVID | Post Acute Sequelae of COVID-19 | Long COVID-19United States
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 Vaccines | COVID-19 Virus DiseaseIndonesia
-
University of Witten/HerdeckeInstitut für Rehabilitationsforschung NorderneyCompletedPost-COVID-19 Syndrome | Long-COVID-19 SyndromeGermany
-
Jonathann Kuo, MDActive, not recruitingSARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditionsUnited States
-
University Hospital, Ioannina1st Division of Internal Medicine, University Hospital of IoanninaRecruitingCOVID-19 Pneumonia | COVID-19 Respiratory Infection | COVID-19 Pandemic | COVID-19 Acute Respiratory Distress Syndrome | COVID-19-Associated Pneumonia | COVID 19 Associated Coagulopathy | COVID-19 (Coronavirus Disease 2019) | COVID-19-Associated ThromboembolismGreece
Clinical Trials on Multicomponent exercise program
-
Hospital de la RiberaUniversity of ValenciaWithdrawnFrailty | Functional Recovery | Geriatric SyndromesSpain
-
European University SpainPublic Health Service of MadridNot yet recruiting
-
National Yang Ming UniversityUnknown
-
Shu-Hung ChangChang Gung Memorial HospitalCompleted
-
Fundacion Miguel ServetHospital Universitario Getafe; Matia FoundationUnknownCognitive Impairment | Frail Elderly SyndromeSpain
-
Montreal Heart InstituteActive, not recruitingNeurodegenerative Diseases | Primary Progressive Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Non-fluent AphasiaCanada
-
Universidad de MurciaCompletedPhysical Activity | Frail Elderly Syndrome | AgingSpain
-
Complejo Hospitalario Universitario de AlbaceteRecruiting
-
University of ChicagoRecruitingAsthma in ChildrenUnited States
-
Fundacion Miguel ServetRecruitingCancer | Aging | Hospital Acquired Condition | DebilitySpain